NASDAQ:SRTS - Sensus Healthcare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$7.12 0.00 (0.00 %)
(As of 08/21/2018 10:34 AM ET)
Previous Close$7.12
Today's RangeN/A
52-Week Range$4.31 - $7.71
VolumeN/A
Average Volume20,641 shs
Market Capitalization$95.79 million
P/E Ratio-25.43
Dividend YieldN/A
Beta-1.37
Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.

Receive SRTS News and Ratings via Email

Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SRTS
CUSIPN/A
Phone561-922-5808

Debt

Debt-to-Equity Ratio0.39
Current Ratio3.80
Quick Ratio3.49

Price-To-Earnings

Trailing P/E Ratio-25.43
Forward P/E Ratio-41.88
P/E GrowthN/A

Sales & Book Value

Annual Sales$20.59 million
Price / Sales4.69
Cash FlowN/A
Price / CashN/A
Book Value$0.87 per share
Price / Book8.18

Profitability

EPS (Most Recent Fiscal Year)($0.28)
Net Income$-3,710,000.00
Net Margins-13.07%
Return on Equity-26.74%
Return on Assets-15.70%

Miscellaneous

Employees45
Outstanding Shares13,550,000
Market Cap$95.79 million

Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare Inc (NASDAQ:SRTS) announced its quarterly earnings data on Thursday, August, 2nd. The company reported ($0.04) EPS for the quarter, missing the Zacks' consensus estimate of ($0.03) by $0.01. The firm earned $6.06 million during the quarter, compared to analysts' expectations of $6.36 million. Sensus Healthcare had a negative net margin of 13.07% and a negative return on equity of 26.74%. View Sensus Healthcare's Earnings History.

When is Sensus Healthcare's next earnings date?

Sensus Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for Sensus Healthcare.

What price target have analysts set for SRTS?

2 brokers have issued 1 year price targets for Sensus Healthcare's stock. Their forecasts range from $9.00 to $12.50. On average, they expect Sensus Healthcare's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 51.0% from the stock's current price. View Analyst Price Targets for Sensus Healthcare.

What is the consensus analysts' recommendation for Sensus Healthcare?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensus Healthcare.

Who are some of Sensus Healthcare's key competitors?

Who are Sensus Healthcare's key executives?

Sensus Healthcare's management team includes the folowing people:
  • Mr. Joseph C. Sardano, Chairman, CEO & Pres (Age 65)
  • Mr. Arthur R. Levine, Chief Financial Officer (Age 60)
  • Mr. Kalman Fishman, COO & CTO (Age 47)
  • Mr. Michael Sardano, Gen. Counsel, Corp. Sec. and Director of Governance & Regulatory (Age 30)
  • Mr. Richard Golin, Exec. VP of International (Age 64)

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Has Sensus Healthcare been receiving favorable news coverage?

News coverage about SRTS stock has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sensus Healthcare earned a media and rumor sentiment score of 0.14 on Accern's scale. They also gave news coverage about the company an impact score of 43.02 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for Sensus Healthcare.

Who are Sensus Healthcare's major shareholders?

Sensus Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional investors include Perkins Capital Management Inc. (1.82%), Renaissance Technologies LLC (0.20%), BlackRock Inc. (0.17%) and Paradigm Capital Management Inc. NY (0.15%). Company insiders that own Sensus Healthcare stock include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Institutional Ownership Trends for Sensus Healthcare.

Which institutional investors are buying Sensus Healthcare stock?

SRTS stock was purchased by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., BlackRock Inc., Paradigm Capital Management Inc. NY and Renaissance Technologies LLC. View Insider Buying and Selling for Sensus Healthcare.

How do I buy shares of Sensus Healthcare?

Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $7.12.

How big of a company is Sensus Healthcare?

Sensus Healthcare has a market capitalization of $95.79 million and generates $20.59 million in revenue each year. The company earns $-3,710,000.00 in net income (profit) each year or ($0.28) on an earnings per share basis. Sensus Healthcare employs 45 workers across the globe.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected]


MarketBeat Community Rating for Sensus Healthcare (NASDAQ SRTS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  67 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  128
MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote "Outperform" if you believe SRTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRTS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by MarketBeat.com Staff

Featured Article: Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel